Start by mapping the real clinical workflow, the systems staff must reach, and the points where login friction slows care. Then test whether the technology reduces steps without creating new access barriers or safety issues. The best measure is not simply uptime or adoption, but whether clinicians can get the right information quickly enough to support safe, informed decisions at the bedside.
How to Judge Clinical Identity Technology Before You Buy It
Evaluate the technology against real bedside work, not an idealised login flow. A tool can look strong in a demo and still fail if it adds screen hops, breaks round-to-round continuity, or delays access to charts, meds, imaging, or orders. The question is whether it fits the clinical moment without forcing clinicians to work around it.
That means testing with the people who will use it, on the devices and workflows they actually rely on, including shared workstations, mobile access, and handoffs. For a useful baseline on access models and governance, see IAM and IGA Basics, which helps frame authentication, authorization, and access review before implementation.
It also helps to look beyond raw feature lists. A clinician-facing identity control should support the minimum necessary access pattern, reduce avoidable reauthentication, and preserve fast recovery when a badge, token, or session fails. If the technology introduces more work than it removes, adoption will be superficial even if the control is technically sound.
What to Test in a Clinical Pilot
Run the pilot against the highest-friction scenarios: urgent chart access, medication administration, covering another clinician’s patient, and returning to work after a break in the shift. Those are the moments where identity and access design either supports care or slows it. A vendor claim about “single sign-on” is only useful if it materially shortens the path to the right system at the bedside.
Test whether the solution supports safe access transitions across different roles and settings, including nurses, physicians, pharmacists, and temporary or rotating staff. Healthcare organisations should also confirm how the product handles identity lifecycle events such as onboarding, role change, and removal of access when staff move departments or leave. A broader lifecycle view is captured well in NHI Lifecycle Management Guide, even where the population is workforce identity rather than machine identity.
Usability testing should include failure states, not just the happy path. If a badge is lost, a token expires, or a device is replaced, clinicians still need a controlled and timely way back into care systems. The best pilot findings come from observing where the product forces workarounds, duplicate logins, or help desk calls during realistic clinical pressure.
What Good Looks Like for Safe Adoption
Good evaluation balances speed, safety, and governance. Clinicians should reach authorised systems quickly, but the organisation still needs clear role-based access, appropriate step-up checks for sensitive functions, and evidence that access can be reviewed and removed cleanly. The right metric is not just uptime, it is whether access remains fast enough for care while staying bounded to what each role actually needs.
Healthcare teams should also pay attention to environment fit. Shared workstations, shift work, break-glass access, and third-party support all create different identity risks and different usability constraints. A product that works for office staff may fail on the ward if it cannot handle rapid context switching, shared devices, or time-sensitive escalation without creating unsafe delay. For healthcare-specific context, Healthcare Identity Security Guide is useful for understanding clinician access patterns, shared workstations, and regulated care environments.
Decision-makers should also compare the product against a reference architecture, not just against competing vendors. The best comparison shows whether the tool reduces friction while keeping auditability, delegation, and access governance intact. If the pilot cannot demonstrate that balance in live workflow, the organisation should treat the rollout as incomplete, even if users initially prefer the interface.
Risk and Threat Considerations
Clinician-facing identity controls can create safety and security risk when they are too rigid, too permissive, or too hard to recover from. Overly strict authentication can delay care, while weak access governance can expose patient data or let users retain access they should no longer have.
Failure mechanism: The control either interrupts care at the point of need or leaves excessive, shared, or stale access in place. In practice, that means users bypassing the intended process, reusing sessions in unsafe ways, or accumulating permissions that no longer match their role.
Impact: Delayed treatment, weaker auditability, and a higher chance of inappropriate access to clinical systems and patient information. In a care setting, the risk is not just technical exposure, it is also operational delay at moments where clinicians need fast, reliable access.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-53 Rev 5 and CIS Controls v8 set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-53 Rev 5 | IA-2 — Identification and Authentication (Organizational Users) | Clinician workforce access depends on strong authentication for organisational users. |
| AC-6 — Least Privilege | Clinical access should be limited to the minimum needed for safe care. | |
| Recommendation — Validate that clinician authentication is fast, reliable, and tied to approved roles. Enforce least privilege so clinicians reach only the systems and functions they need. | ||
| CIS Controls v8 | CIS-6 — Access Control Management | Rollout evaluation hinges on managing access paths, approvals, and revocation. |
| Recommendation — Test that access provisioning and revocation remain controlled during real clinical workflows. | ||
| ISO/IEC 27001:2022 | A.5.15 — Access control | Clinical identity technology must preserve controlled access to regulated systems and data. |
| A.8.5 — Secure authentication | Clinician login friction and safe reauthentication are central to rollout success. | |
| Recommendation — Define and enforce access rules that fit clinical roles and emergency use cases. Confirm authentication is secure yet usable enough for bedside workflows. | ||
Practitioner Guidance
What to prioritise: Prioritise workflow fit over feature breadth. A smaller control set that clinicians can use reliably is usually better than a richer platform that needs workarounds at the bedside.
What to verify: Verify that the solution works across the full care path, including shared workstations, shift handoffs, emergency access, and account recovery. If any of those scenarios require manual exception handling every day, the design is not mature enough for rollout.
Decision rule: If the product shortens access time but makes governance opaque, reject it; if it improves governance but slows care, redesign the rollout before expanding scope.
Practitioner takeaway: The right buying decision is the one that proves clinicians can reach the right information quickly, safely, and with access that remains explainable after the pilot ends.
Related resources from NHI Mgmt Group
- Should organisations tighten access reviews before rolling out Copilot?
- How should organisations evaluate identity assurance before allowing high-risk transactions or access?
- How should organisations evaluate an eSignature vendor before rolling out digital signing at scale?
- Why should organisations put identity governance before rolling out SSO and MFA?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 27, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org